Latest Press Releases
Jul 1, 2019 • 7:00am EDT
Synthetic Biologics Regains Compliance with NYSE American Continued Listing Standards
ROCKVILLE, Md., July 1, 2019 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, announced today receipt, on June 28, 2019, of notification from the NYSE American LLC (the "Exchange") that the Company has regained compliance with Part 10, Section 1003 of the NYSE American's Company Guide (the "Company Guide") relating to the Exchange's continued listing requirements. ...